Seattle Children’s Hospital
Date of Award
Type 1 Diabetes, Prevent & Delay
Term of Grant
Development of antigen-specific enhanced T-reg therapy in T1D
Funds support a work into a preclinical proof-of-principle for an engineered targeted Treg cell therapy to treat type 1 diabetes.